Once burgeoning New York hemp firms are now embroiled in a legal showdown with the state’s Office of Cannabis Management. The companies allege that recently enforced directives over hemp-derived cannabinoid goods have resulted in “millions of dollars in losses” and are pushing back against these regulations in a federal court.
The alterations to the rules around products containing cannabinoids have sent shock waves through the hemp industry in New York State. Hemp producers who were anticipating enormous growth and fruitful profits have been hit hard by the regulations, which they say betray promises of a thriving industry and have left businesses hemorrhaging money and grappling with unforeseen difficulties.
Multiple hemp companies, as regulated by New York State, have launched a lawsuit against the Office of Cannabis Management, alleging the claims. The primary contention of the plaintiffs is that the newly imposed strictures have led to severe economic strain and obstructed their operational atmosphere.
In the filing, the companies allege that the state is stepping beyond the authority granted by the 2018 Farm Bill – the ruling U.S. federal law that permits hemp production and sets controls for hemp and hemp-derived product operations.
The current lawsuit, if successful, could have far-reaching implications for an industry already dogged by controversy and disparate regulatory frameworks across the country. It could pave the way for more legal actions from aggrieved hemp producers, not only in New York but other states where producers feel stifled by oppressive regulations.
With these regulations and the subsequent lawsuit, the availability of cannabinoid goods for medical purposes might be undermined. As legal battles rage, access to these products may become more challenging for patients. It is in such instances that MMJ.com steps in to offer a solution. It provides easy access to medical marijuana cards for new patients and offers renewals for those already making use of the service.
Learn more about applying for a New York medical marijuana card here.
The legal tussle is much more than a fight for survival for hemp companies in New York. It is a critical turning point that could determine the future trajectory of the hemp industry in the state and possibly nationwide. This case is emblematic of the broader struggles faced by hemp and medical marijuana businesses that aim to operate amidst a complex matrix of laws and regulations.
